Dr. Gabrielle Carlson, Pharma, CABF, and the Medicaid-ed Child
This is a post that shows you how I research, find one piece of information and then another, and another until it shows again, how these people quoted as KOL's (Key Opinion Leaders) in print papers such as the NYTimes is a dicey subject when considering this woman's quote from the recent article in the Times, regarding Medicaid children more likely to be placed on antipsychotics:
"Maybe Medicaid kids are getting better treatment,” said Dr. Gabrielle Carlson, a child psychiatrist and professor at the Stony Brook School of Medicine. “If it helps keep them in school, maybe it’s not so bad.”--Dr. Gabrielle Carlson
---
Go to the links provided here and decide for yourself if you believe she is interested in those kids gaining an education, or if she might just be a little bit influenced by Joseph Biederman and the Pharma-Pro-drugging idealists at CABF, or even influenced by the companies themselves for pimping out some cash!
Dr. Gabrielle Carlson
http://www.hsc.stonybrook.edu/som/psychiatry/carlson_g.cfm
Training: Wellesley CollegeMedical school: Cornell University Medical SchoolMedicine internship: Jewish Hospital – St. Louis.Psychiatry: Washington University – dept. of psychiatry, National Institute of Mental Health.Child Psychiatry: University of California, LA, Neuropsychiatric Institute.
Treatment Specialties: Second opinion evaluations of child/adolescent.
Emotional and behavioral problems.
Mood/Bipolar disorder in children and adolescents, ADHD.
Research Interests: Bipolar Disorder in children and adolescents, child psychopharmacology.
http://www.nytimes.com/2007/02/15/us/15bipolar.html
Carlson was heard from before in Feb 2007 in an article in the NYTimes about the toddler REBECCA RILEY, who was found DEAD with these drugs in her system:
"Rebecca was taking Seroquel, an antipsychotic drug; Depakote, an equally powerful mood medication; and Clonidine, a blood pressure drug often prescribed to calm children."
"Bipolar is absolutely being overdiagnosed in children, and the major downside is that people then think they have a solution and are not amenable to listening to alternatives,” which may not include drugs, said Dr. Gabrielle Carlson, a professor of psychiatry and pediatrics at Stony Brook University School of Medicine on Long Island." --2007
http://www.aacap.org/cs/2010_psychopharmacology_update_institute/disclosures
2010 Psychopharmacology Update Institute
AACAP 2009 January Psychopharmacology Update Institute: Evidence-Based Treatments in Child Psychiatry
"The AACAP's 2009 Psychopharmacology Update Institute, Child and Adolescent Psychopharmacology: Evidence-Based Treatments and Beyond, chaired by Gabrielle Carlson, M.D., will take place January 23-24 at the Sheraton New York Hotel and Towers in New York, New York. "Children with serious psychiatric disorders are increasingly complex. The experts convened for this Institute have as their goal not only a review of the evidence base of important conditions, but also how to approach situations where the evidence-based treatments don't work," says Institute Chair Dr. Gabrielle Carlson.
Evidence-based psychopharmacologic treatments for serious psychiatric disorders in children and adolescents have grown considerably in the past decade. The evidence-base is comprised of studies that describe both treatments that work, and also the cost of using them. "
The AACAP 2009 January Psychopharmacology Update Institute faculty includes:
Gabrielle A. Carlson, M.D.
Advisor/Consultant: Bristol-Myers Squibb Company, Eli Lilly and Company, Otsuka America Pharmaceutical, Inc., Validus
Honorarium and Travel Expenses: American Academy of Child & Adolescent Psychiatry, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Shire Pharmaceuticals, Inc.
Research Funding: Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Otsuka America Pharmaceutical, Inc.
Spouse Advisor/Consultant: Eli Lilly and Company, H. Lundbeck A/S
---
Gabrielle A. Carlson, M.D., Chair, Professor of Psychiatry and Pediatrics and Director of Child and Adolescent Psychiatry, Stony Brook University School of Medicine
Boris Birmaher, M.D., Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry, University of Pittsburgh School of Medicine
---
http://www.bpkids.org/site/PageServer?pagename=ppl_advisory
Scientific Advisory Council, CABF bpkids.org
Boris Birmaher, M.D.
Professor of PsychiatryUniversity of Pittsburgh Medical CenterWestern Psychiatric Institute and ClinicPittsburgh, PA
http://www.bpkids.org/site/PageServer?pagename=ppl_advisory
Gabrielle Carlson, M.D.
Professor of Psychiatry and Pediatrics, Director of Child and Adolescent Psychiatry, Stonybrook State University of New York
In this recent NYTimes 2009 article she is quoted as saying:
“Maybe Medicaid kids are getting better treatment,” said Dr. Gabrielle Carlson, a child psychiatrist and professor at the Stony Brook School of Medicine. “If it helps keep them in school, maybe it’s not so bad.”--Dr. Gabrielle Carlson
Further reading:
http://www.furiousseasons.com/archives/2009/12/study_medicaid_kids_get_antipsychotics_at_four_times_the_rate_of_privatelyinsured_kids.html
http://www.nytimes.com/2009/12/12/health/12medicaid.html?_r=1
http://bipolar-stanscroniclesandnarritive.blogspot.com/2009/12/another-tragic-case-of-big-pharma.html
http://bipolarsoupkitchen-stephany.blogspot.com/2009/11/to-us-fda-anti-psychotics-need.html
http://bipolarsoupkitchen-stephany.blogspot.com/2009/07/florida-fails-foster-kids-psych-drugs.html
http://bipolarsoupkitchen-stephany.blogspot.com/2009/07/rebecca-riley-dead-at-age-4-grand-jury.html
http://bipolarsoupkitchen-stephany.blogspot.com/2008/02/1999-2008-ocd-adhd-childhood-bipolar.html
Subscribe to:
Post Comments (Atom)








2 comments:
fricking spam.
I'm having trouble following (a) exactly what you think it is that you found, and
(b) what you make of it. I love your blog and follow it religiously, but at times--including this morning--wish you would lay out your line of thinking for us!
You obviously have been thorough, though, and I plan to follow the links, as her quote has come up for quite some discussion on a listserv I belong to. She defended her comments as being taken out of context, and herself as being conservative both in her diagnoses and prescribing habits.
Good for you for locating her financial ties to pharmaceutical companies, and thanks for the wealth of links!
What I think I found:
Not a find as much as a reminder that the people typically quoted in print papers and behind the drugging of children are these drug-company-funded KOL's--this woman saying, that the Medicaid kids might be better off receiving "early treatment" which we all know are psych meds--2 years ago she was quoted in the NYTimes as agreeing that the child bipolar dx is over-dx--
Then, I go on to find her associated with the largest parent support groups for children w bipolar CABF; they promote these drugs as needed to prevent suicide as chemo is for cancer patients (they use that analogy a lot)
So, it's not what I have found, but what I confirmed.
You take one name from the article and she is completely immersed in pharma $$$ THEREFORE, how can one trust her judgement on the best care for a medicaid child; secondly I believe she contradicted herself between the 2 articles from 07 and now.
Mostly, I was going after the transparency angle--here is a story everyone is writing about, the drugging of innocent children, and I find exactly what I was looking for, a researcher funded by ALL of the psych med companies, I doubt that she is not influenced by those companies, they gave her the $$ to fund research, and we know how those studies often turn out: in favor of that company's drug.
If she has been defending her comment, then I'd like to see her do a study without pharma money to prove her innocence.
Post a Comment